These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26916070)

  • 81. Chronic lymphocytic leukemia with TP53 gene alterations: a detailed clinicopathologic analysis.
    Liu YC; Margolskee E; Allan JN; Mathew S; Bhavsar E; Casano J; Orazi A; Furman RR; Geyer JT
    Mod Pathol; 2020 Mar; 33(3):344-353. PubMed ID: 31477813
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
    Bertrand P; Bastard C; Maingonnat C; Jardin F; Maisonneuve C; Courel MN; Ruminy P; Picquenot JM; Tilly H
    Leukemia; 2007 Mar; 21(3):515-23. PubMed ID: 17230227
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Specific cutaneous infiltrates of B-cell chronic lymphocytic leukemia: a clinicopathologic and prognostic study of 42 patients.
    Cerroni L; Zenahlik P; Höfler G; Kaddu S; Smolle J; Kerl H
    Am J Surg Pathol; 1996 Aug; 20(8):1000-10. PubMed ID: 8712287
    [TBL] [Abstract][Full Text] [Related]  

  • 84. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
    Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
    Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Submicroscopic genomic imbalances in Burkitt lymphomas/leukemias: association with age and further evidence that 8q24/MYC translocations are not sufficient for leukemogenesis.
    Lundin C; Hjorth L; Behrendtz M; Ehinger M; Biloglav A; Johansson B
    Genes Chromosomes Cancer; 2013 Apr; 52(4):370-7. PubMed ID: 23225516
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study.
    Hleuhel MH; Ben-Dali Y; Da Cunha-Bang C; Brieghel C; Clasen-Linde E; Niemann CU; Andersen MA
    BMJ Open; 2019 Mar; 9(3):e023566. PubMed ID: 30833314
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A clinicopathologic study of familial chronic lymphocytic leukemia.
    Shah AR; Maeda K; Deegan MJ; Roth MS; Schnitzer B
    Am J Clin Pathol; 1992 Feb; 97(2):184-8. PubMed ID: 1546686
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Discordant differentiation antigen pattern in a case of Richter's syndrome with monoclonal idiotype expression and immunoglobulin gene rearrangement.
    van Endert PM; Mechtersheimer G; Möller P; Dörken B; Hämmerling GJ; Moldenhauer G
    Br J Cancer; 1990 Aug; 62(2):248-52. PubMed ID: 2386740
    [No Abstract]   [Full Text] [Related]  

  • 89. Hodgkin's lymphoma as a rare variant of Richter's transformation in chronic lymphocytic leukemia: A case report and review of the literature.
    Janjetovic S; Bernd HW; Bokemeyer C; Fiedler W
    Mol Clin Oncol; 2016 Mar; 4(3):390-392. PubMed ID: 26998289
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Atypical rearrangement involving 3'-IGH@ and a breakpoint at least 400 Kb upstream of an intact MYC in a CLL patient with an apparently balanced t(8;14)(q24.1;q32) and negative MYC expression.
    Amarillo I; Bui PH; Kantarci S; Rao N; Shackley BS; García R; Tirado CA
    Mol Cytogenet; 2013 Feb; 6(1):5. PubMed ID: 23369149
    [TBL] [Abstract][Full Text] [Related]  

  • 91. An unusual case of chronic lymphocytic leukemia/small lymphocytic lymphoma with nodular morphology.
    Shanmugam V; Dorfman DM
    Leuk Lymphoma; 2017 Aug; 58(8):2014-2016. PubMed ID: 27919167
    [No Abstract]   [Full Text] [Related]  

  • 92. Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study.
    Younes A; Brody J; Carpio C; Lopez-Guillermo A; Ben-Yehuda D; Ferhanoglu B; Nagler A; Ozcan M; Avivi I; Bosch F; Caballero Barrigón MD; Hellmann A; Kuss B; Ma DDF; Demirkan F; Yağci M; Horowitz NA; Marlton P; Cordoba R; Wrobel T; Buglio D; Streit M; Hodkinson BP; Schaffer M; Alvarez J; Ceulemans R; Balasubramanian S; de Jong J; Wang SS; Fourneau N; Jurczak W
    Lancet Haematol; 2019 Feb; 6(2):e67-e78. PubMed ID: 30642819
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Expression of the c-myc proto-oncogene in multiple myeloma and chronic lymphocytic leukemia: an in situ analysis.
    Greil R; Fasching B; Loidl P; Huber H
    Blood; 1991 Jul; 78(1):180-91. PubMed ID: 2070052
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Molecular characteristics of terminal deoxynucleotidyl transferase negative precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement.
    Yoon J; Yun JW; Jung CW; Ju HY; Koo HH; Kim SH; Kim HJ
    Genes Chromosomes Cancer; 2020 Apr; 59(4):255-260. PubMed ID: 31705772
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Richter's syndrome of T-cell lineage (T rex lymphoma).
    Roncati L
    Curr Med Res Opin; 2020 Mar; 36(3):473-476. PubMed ID: 31910677
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Clinical characteristics and prognosis of concurrent positive t(14; 18) and myc gene rearrangement in diffuse large B cell lymphoma].
    Zhang HW; Chen ZW; Wang LY; He JX; Zheng YP; Han WE; Yang B; Wang YL; Zhao ZQ; Bai M; Su LP
    Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):206-10. PubMed ID: 26988827
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Leptomeningeal involvement in B-cell chronic lymphocytic leukemia: a case report and review of the literature.
    de Souza SL; Santiago F; Ribeiro-Carvalho Mde M; Arnóbio A; Soares AR; Ornellas MH
    BMC Res Notes; 2014 Sep; 7():645. PubMed ID: 25218117
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Comparison of karyotype scoring guidelines for evaluating karyotype complexity in chronic lymphocytic leukemia.
    Avenarius MR; Huang Y; Kittai AS; Bhat SA; Rogers KA; Grever MR; Woyach JA; Miller CR
    Leukemia; 2024 Mar; 38(3):676-678. PubMed ID: 38374409
    [No Abstract]   [Full Text] [Related]  

  • 99. The t(11;14)(q13;q32)/CCND1-IGH translocation is a recurrent secondary genetic aberration in relapsed chronic lymphocytic leukemia.
    Schliemann I; Oschlies I; Nagel I; Maria Murga Penas E; Siebert R; Sander B
    Leuk Lymphoma; 2016 Nov; 57(11):2672-6. PubMed ID: 26916968
    [No Abstract]   [Full Text] [Related]  

  • 100. Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL.
    Barr PM; Saylors GB; Spurgeon SE; Cheson BD; Greenwald DR; O'Brien SM; Liem AK; Mclntyre RE; Joshi A; Abella-Dominicis E; Hawkins MJ; Reddy A; Di Paolo J; Lee H; He J; Hu J; Dreiling LK; Friedberg JW
    Blood; 2016 May; 127(20):2411-5. PubMed ID: 26968534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.